Head-to-head dispatch
Fitish vs HealthSource
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Oral-capable, LegitScript-verified, and nationwide — trust signals are strong, but pricing sits mid-to-high.
Marked down on: Higher pricing than the value leaders
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Desk Score
HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.
Marked down on: No physician names or clinical leadership disclosed on public pages
Fitish takes this head-to-head with the higher Desk Score, 85/100 (B) against 84/100 (B) for HealthSource. HealthSource still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Fitish
85/100
B
HealthSource
84/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Fitish | HealthSource |
|---|---|---|
| Semaglutide | $219/mo | $199/mo (all doses, compounded) |
| Tirzepatide | $339/mo | $299/mo (all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who prioritize a verified pharmacy and oral options over finding the lowest rate. | Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo. |
| Desk Score | 85/100B | 84/100B |
The verdict
Desk pick — FitishFitish takes this head-to-head with the higher Desk Score, 85/100 (B) against 84/100 (B) for HealthSource. HealthSource still holds its ground where its strengths line up with yours.
Choose Fitish if…
People who prioritize a verified pharmacy and oral options over finding the lowest rate.
$219/mo sema · $339/mo tirz · All 50 states
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Choose HealthSource if…
Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.
$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Fitish · HealthSource.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Fitish vs CoreAge Rx
- HealthSource vs Vaylen
- Fitish vs Strut Health
- HealthSource vs Ondra Health
- Fitish vs Invigor Medical
- HealthSource vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.